Pro Medicus share price rockets 13% on biggest ever contract win

Pro Medicus shares are leaping higher on Thursday.

| More on:
Researchers and doctors with futuristic 3d hologram overlay for body anatomy or dna in hospital clinic.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Pro Medicus Ltd (ASX: PME) share price just took a huge leg up in intraday trading.

Shares in the S&P/ASX 200 Index (ASX: XJO) health imaging company closed yesterday at $228.41. They were trading 1.5% higher at 1.30pm AEDT today before rocketing to $258.87, up 13.3%.

After some likely profit-taking, Pro Medicus shares are currently changing hands for $247.25 each, up 8.4%.

As you can see on the chart below, this sees the Pro Medicus stock up an eye-watering 184% in just 12 months.

Here's what's spurring ASX 200 investor interest this afternoon.

Pro Medicus share price soars on $330 million deal

The Pro Medicus share price just took off after the company released an intraday update regarding a major new contract.

Pro Medicus reported that its wholly owned United States subsidiary, Visage Imaging, has signed a 10-year $330 million contract with Trinity Health.

Trinity Health is one of the largest not-for-profit healthcare systems in the US, with 93 hospitals, 107 continuing care locations, and 142 urgent care locations.

The contract will see the ASX 200 healthcare stock's cloud-based Visage 7 Enterprise Imaging Platform implemented throughout Trinity to provide a unified diagnostic imaging platform.

Pro Medicus noted that Trinity Health, like all its recent Visage 7 clients, has opted for a fully cloud-based solution. The company said this is a trend that is "fast becoming the standard in the North American healthcare IT market".

Management said that planning for the rollout would start immediately. The rollout will be based on Visage's proven cloud-based implementation process. Multi-phased go-lives are targeted to begin in early Q3 of the 2025 calendar year.

Commenting on the contract sending the Pro Medicus share price soaring, CEO Sam Hupert said:

Trinity Health is our largest customer to date and the first with a national footprint. Our initiative with Trinity Health is noteworthy for its scope and scale which will see the Visage 7 platform used by over 650 Radiologists and thousands of clinicians who will benefit from the proven differentiation of Visage 7…

Our pipeline remains strong and spans all market segments. As has been the case with many of our recent contracts, this deal is for our 'full-stack' comprising all three core Visage products, a trend we see continuing.

If the Pro Medicus share price manages to hold onto the gains at close, as looks likely to me, this will mark another new all-time closing higher for the ASX 200 health imaging company.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
Healthcare Shares

Guess which ASX healthcare stock is jumping 12% on Wednesday

This shares is rocketing this morning. But why? Let's find out.

Read more »

Man holding out Australian dollar notes, symbolising dividends.
Healthcare Shares

Here is the dividend forecast to 2029 for CSL shares

Can this blue-chip giant provide healthy dividend income?

Read more »

a doctor in a white coat makes a heart shape with his hands and holds it over his chest where his heart is placed.
Healthcare Shares

The best ASX 200 healthcare stocks to buy in 2025

These shares could give your portfolio a healthy boost next year according to Bell Potter.

Read more »

In the lab at work, the mature adult woman and young adult man smile as they review the results of their successful experimentation.
Healthcare Shares

ASX 300 healthcare stock lifts off on promising new results

Up 28% in a year, the ASX healthcare stock is leaping higher on Thursday.

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

If you'd invested $5,000 in this ASX 300 healthcare stock a year ago, you'd now have $30,000!

This stock has made millions for investors over just a few months.

Read more »

Male doctor in a lab coat working at laptop looking serious.
Healthcare Shares

Has the Pro Medicus share price risen too high too quickly?

Pro Medicus shares have rocketed 173% since this time last year.

Read more »

A senior pharmacist talks to a customer at the counter in a shop
Mergers & Acquisitions

Own Sigma shares? Here's the latest on the Chemist Warehouse merger

One year ago today, the two companies announced plans to merge. We could now be just a few months away…

Read more »

Man with a sleep apnoea mask on whilst sleeping.
Healthcare Shares

'Huge opportunity' ahead for this ASX 200 healthcare stock

The ASX 200 healthcare stock is facing a large untapped market for its lead products.

Read more »